Current approaches and perspectives in human keratinocyte-based gene therapies.
about
Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cellsGene therapy in combination with tissue engineering to treat epidermolysis bullosa.Biological skin substitutes for wound cover and closure.Progress and prospects: gene therapy clinical trials (part 2).Engineered Epidermal Progenitor Cells Can Correct Diet-Induced Obesity and Diabetes.Inhibition of Apoptosis by Expression of Antiapoptotic Proteins in Recombinant Human Keratinocytes.
P2860
Current approaches and perspectives in human keratinocyte-based gene therapies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Current approaches and perspectives in human keratinocyte-based gene therapies.
@ast
Current approaches and perspectives in human keratinocyte-based gene therapies.
@en
type
label
Current approaches and perspectives in human keratinocyte-based gene therapies.
@ast
Current approaches and perspectives in human keratinocyte-based gene therapies.
@en
prefLabel
Current approaches and perspectives in human keratinocyte-based gene therapies.
@ast
Current approaches and perspectives in human keratinocyte-based gene therapies.
@en
P2093
P2860
P356
P1433
P1476
Current approaches and perspectives in human keratinocyte-based gene therapies.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3302370
P478
11 Suppl 1
P577
2004-10-01T00:00:00Z